📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-12 17:28
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
2 announcements match the current filters (relevance ≥ 5).
Rs 10.84 Lakh PAT: Indo Euro Indchem Q1 FY27 Revenue Grows 163% YoY to Rs 4.05 Cr
Indo Euro Indchem reported a standalone revenue of Rs 4.05 Cr for Q1 FY27, representing a 163% increase compared to Rs 1.54 Cr in Q1 FY26. However, Net Profit declined to Rs 10.84 Lakhs from Rs 15 Lakhs in the same period last year, as the company faced higher relative operating costs. The company operates exclusively in the trading segment, which is characterized by thin margins, reflected in a PBT margin of 3.5% this quarter. While revenue is up YoY, it represents a significant sequential decline from the Rs 8.12 Cr reported in Q4 FY26.
Confidence: HIGH
What changedThe company has transitioned into the new financial year (FY27) with a significant YoY revenue jump but lower profitability compared to the previous year's first quarter.
Why it mattersFor a micro-cap entity with a market cap of only Rs 8 Cr, the shift from manufacturing-like margins to a pure trading model (as indicated in segment reporting) results in high volume requirements to sustain even small absolute profits.
Revenue (Q1 FY27): Rs 4.05 CrNet Profit (Q1 FY27): Rs 10.84 LakhsRevenue vs TTM Revenue: 28.9%PBT Margin: 3.5%EPS: Rs 0.12
📅 Short termThe stock is likely to remain range-bound given the small absolute profit figures and the sharp sequential decline in revenue compared to Q4 FY26.
📈 Long termLimited structural significance; the company remains a small-scale trading business with thin margins and volatile quarterly performance.
⚠ Risk flags
- Micro-cap liquidity risk
- Thin operating margins in trading segment
- High sequential revenue volatility
Key Highlights
Revenue from operations reached Rs 4.05 Cr in Q1 FY27, up from Rs 1.54 Cr in Q1 FY26.
Net Profit for the quarter stood at Rs 10.84 Lakhs, a decline from Rs 15 Lakhs in the year-ago period.
Purchases of stock-in-trade were high at Rs 4.17 Cr, offset by a negative inventory change of Rs 75.27 Lakhs.
Earnings Per Share (EPS) for the quarter was reported at Rs 0.12.
Total expenses for the quarter were Rs 4.00 Cr, nearly matching the total income of Rs 4.14 Cr.
👀 What to Watch
Investors should monitor the company's ability to maintain trading volumes and stabilize margins, as the micro-cap nature (Rs 8 Cr market cap) makes the stock highly sensitive to small changes in operational efficiency.
Indo Euro Indchem Q1 Revenue Grows 86% YoY to ₹3.14 Cr; Net Profit at ₹0.11 Cr
Indo Euro Indchem reported a significant year-on-year revenue growth of 85.8%, reaching ₹3.14 Cr in Q1 FY27 compared to ₹1.69 Cr in Q1 FY26. However, revenue saw a sharp sequential decline of 61.9% from the ₹8.24 Cr reported in Q4 FY26. Net profit for the quarter stood at ₹0.11 Cr, down from ₹0.15 Cr in the same period last year, reflecting compressed margins. The company continues to operate as a pure-play chemical trader with a very small market capitalization of ₹8 Cr.
Confidence: HIGH
What changedThe company released its unaudited financial results for the first quarter of FY27 and confirmed the re-appointment of its audit firms.
Why it mattersFor a micro-cap company with a market cap of only ₹8 Cr, quarterly performance is highly volatile; the YoY revenue jump shows scaling potential, but the QoQ drop highlights inconsistency.
Revenue (Q1 FY27): ₹3.14 CrNet Profit (Q1 FY27): ₹0.11 CrYoY Revenue Growth: 85.8%QoQ Revenue Growth: -61.9%Market Cap: ₹8 Cr
📅 Short termThe stock may remain range-bound as the absolute profit remains negligible and the sequential revenue decline is substantial.
📈 Long termLimited structural significance unless the company transitions from trading to manufacturing or significantly scales its trading volumes with better margins.
⚠ Risk flags
- High sequential revenue volatility
- Low operating margins typical of trading businesses
- Micro-cap liquidity risk
Key Highlights
Revenue from operations increased to ₹3.14 Cr in Q1 FY27 from ₹1.69 Cr in Q1 FY26.
Net profit for the quarter ended June 30, 2026, was ₹0.11 Cr vs ₹0.15 Cr YoY.
Total expenses for the quarter rose to ₹3.00 Cr, primarily driven by purchase of stock-in-trade.
Earnings Per Share (EPS) for the quarter was ₹0.12, compared to ₹0.16 in the previous year's corresponding quarter.
Re-appointed VKMG & Associates LLP and Moxit & Associates as Secretarial and Internal Auditors respectively for FY 2026-27.
👀 What to Watch
Watch for consistency in quarterly revenue and any signs of margin expansion beyond the current low single digits. Given the micro-cap nature, liquidity and execution risks remain high.
